Abstract
Summary
Objective
To evaluate common surgical procedures and admission causes in inpatient cases with diabetes in Germany between 2015 and 2019 and compare them to inpatient cases without diabetes.
Methods
Based on the German diagnosis-related groups (G-DRG) statistics, regression models stratified by age groups and gender were used to calculate hospital admissions/100,000 individuals, hospital days as well as the proportion of complications and mortality in inpatient cases ≥ 40 years with or without a documented diagnosis of diabetes (type 1 or type 2).
Results
A total of 14,222,326 (21%) of all inpatient cases aged ≥ 40 years had a diagnosis of diabetes. More middle-aged females with vs. without diabetes/100,000 individuals [95% CI] were observed, most pronounced in cases aged 40–< 50 years with myocardial infarction (305 [293–319] vs. 36 [36–37], p < 0.001). Higher proportions of complications and longer hospital stays were found for all procedures and morbidities in cases with diabetes.
Conclusion
Earlier hospitalizations, longer hospital stays and more complications in inpatient cases with diabetes together with the predicted future increase in diabetes prevalence depict huge challenges for the German healthcare system. There is an urgent need for developing strategies to adequately care for patients with diabetes in hospital.
Funder
Deutsches Zentrum für Diabetesforschung
Robert Koch Institut
Deutsche Diabetes Gesellschaft
Universität Ulm
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Tönnies T, Rathmann W. Epidemiologie des Diabetes in Deutschland. In: Deutsche Diabetes Gesellschaft (DDG) und diabetesDE, editor. Deutscher Gesundheitsbericht, Diabetes 2021. 2020. pp. 10–8.
2. Heidemann C, Du Y, Paprott R, Haftenberger M, Rathmann W, Scheidt-Nave C. Temporal changes in the prevalence of diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the German health interview and examination surveys in 1997–1999 and 2008–2011. Diabet Med. 2015;33(10):1406–14.
3. Ampofo AG, Boateng EB. Beyond 2020: modelling obesity and diabetes prevalence. Diabetes Res Clin Pract. 2020;167:108362.
4. Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis. 2018;25(2):121–32.
5. Jacobs E, Hoyer A, Brinks R, Icks A, Kuss O, Rathmann W. Healthcare costs of type 2 diabetes in Germany. Diabet Med. 2017;34(6):855–61. https://doi.org/10.1111/dme.13336.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献